Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting
Open Access
- 1 April 2012
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 148 (4), 487-494
- https://doi.org/10.1001/archdermatol.2012.370
Abstract
Psoriasis is a common, chronic inflammatory disease of the skin and joints mediated by types 1 and 17 helper T cells.1,2 It can develop at any age, but onset most commonly occurs in young adulthood. The disease is believed to be incurable and long-term spontaneous remissions are rare. Psoriasis is associated with impairment in physical and emotional health even in patients with mild disease, and patients with psoriasis requiring systemic therapy or phototherapy (ie, those with moderate to severe disease) have an increased risk of major cardiovascular events and mortality independent of traditional risk factors.3-9Keywords
This publication has 29 references indexed in Scilit:
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusionsJournal of the American Academy of Dermatology, 2011
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004Journal of the American Academy of Dermatology, 2009
- Translating the Science of Quality of Life into Practice: What Do Dermatology Life Quality Index Scores Mean?Journal of Investigative Dermatology, 2005
- Determinants of quality of life in patients with psoriasis: A study from the US populationJournal of the American Academy of Dermatology, 2004
- A Modified Poisson Regression Approach to Prospective Studies with Binary DataAmerican Journal of Epidemiology, 2004
- Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment DissatisfactionJournal of Investigative Dermatology Symposium Proceedings, 2004
- Randomized Clinical Trials for Psoriasis 1977–2000: The EDEN SurveyJournal of Investigative Dermatology, 2003
- Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.Archives of Neurology, 2001
- Psoriasis causes as much disability as other major medical diseasesJournal of the American Academy of Dermatology, 1999
- What's the Relative Risk?JAMA, 1998